Status:
NOT_YET_RECRUITING
Vitamin K Antagonist in Rheumatic Heart Disease Patients With Mechanical Heart Valves: Our Current Status
Lead Sponsor:
Ahmed Hassan Rostom Ibrahim
Conditions:
Rheumatic Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
VKA in RHD patients with MHV: our current status
Detailed Description
Vitamin K Antagonist in Rheumatic heart disease patients with mechanical heart valves: Our Current Status
Eligibility Criteria
Inclusion
- Confirmed presence of a mechanical heart valve.
- Aged ≥18 years
Exclusion
- Pregnancy.
- Active bleeding disorders.
- Severe liver/kidney disease (if affecting anticoagulation).
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT07146282
Start Date
September 1 2025
End Date
October 1 2027
Last Update
August 28 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.